Corpus ID: 79650269

Efectividad y seguridad de la oxibutinina o tolterodina comparado con darifenacina, solifenacina, fesoterodina y placebo para el tratamiento de la incontinencia

@inproceedings{Contreras2014EfectividadYS,
  title={Efectividad y seguridad de la oxibutinina o tolterodina comparado con darifenacina, solifenacina, fesoterodina y placebo para el tratamiento de la incontinencia},
  author={Javier Contreras and P. Serrano and Egdda Patricia Vanegas Escamilla and H. Aponte and Jaime Andr{\'e}s Olivos},
  year={2014}
}
  • Javier Contreras, P. Serrano, +2 authors Jaime Andrés Olivos
  • Published 2014
  • Medicine
  • Introduccion: Alrededor del 16% al 45% de los adultos tiene sintomas de vejiga hiperactiva, que se manifiestan con urgencia para orinar, aumento en la frecuencia de micciones o incontinencia urinaria de urgencia, o ambos, denominado sindrome de vejiga hiperactiva. Los farmacos anticolinergicos son los tratamientos mas comunes para el tratamiento farmacologico y entre ellos la oxibutinina y la tolterodina. Esta evaluacion tecnologica se desarrollo en el marco de la actualizacion integral del… CONTINUE READING

    Topics from this paper

    References

    SHOWING 1-10 OF 20 REFERENCES
    Solifenacin for overactive bladder: a systematic review and meta-analysis
    • 28
    • Highly Influential
    Adverse Event Assessment of Antimuscarinics for Treating Overactive Bladder: A Network Meta-Analytic Approach
    • 114
    • PDF
    Treatments for overactive bladder: focus on pharmacotherapy.
    • R. Geoffrion
    • Medicine
    • Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
    • 2012
    • 34
    • PDF
    Which anticholinergic drug for overactive bladder symptoms in adults.
    • 79
    • Highly Influential
    The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    • 4,859
    Global prevalence and economic burden of urgency urinary incontinence: a systematic review.
    • 232
    Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
    • 735
    • PDF
    La incontinencia urinaria
    • 28